首页> 美国卫生研究院文献>other >Generation and validation of homozygous fluorescent knock-in cells using CRISPR/Cas9 genome editing
【2h】

Generation and validation of homozygous fluorescent knock-in cells using CRISPR/Cas9 genome editing

机译:使用CRISPR / Cas9基因组编辑生成纯合荧光敲入细胞并进行验证

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Gene tagging with fluorescent proteins is essential to investigate the dynamic properties of cellular proteins. CRISPR/Cas9 technology is a powerful tool for inserting fluorescent markers into all alleles of the gene of interest (GOI) and permits functionality and physiological expression of the fusion protein. It is essential to evaluate such genome-edited cell lines carefully in order to preclude off-target effects caused by either (i) incorrect insertion of the fluorescent protein, (ii) perturbation of the fusion protein by the fluorescent proteins or (iii) non-specific genomic DNA damage by CRISPR/Cas9. In this protocol, we provide a step-by-step description of our systematic pipeline to generate and validate homozygous fluorescent knock-in cell lines.We have used the paired Cas9D10A nickase approach to efficiently insert tags into specific genomic loci via homology-directed repair with minimal off-target effects. It is time- and cost-consuming to perform whole genome sequencing of each cell clone. Therefore, we have developed an efficient validation pipeline of the generated cell lines consisting of junction PCR, Southern Blot analysis, Sanger sequencing, microscopy, Western blot analysis and live cell imaging for cell cycle dynamics. This protocol takes between 6–9 weeks. Using this protocol, up to 70% of the targeted genes can be tagged homozygously with fluorescent proteins and result in physiological levels and phenotypically functional expression of the fusion proteins.
机译:用荧光蛋白进行基因标记对于研究细胞蛋白的动态特性至关重要。 CRISPR / Cas9技术是将荧光标记物插入目标基因(GOI)的所有等位基因中的强大工具,可实现融合蛋白的功能性和生理表达。至关重要的是,仔细评估此类基因组编辑的细胞系,以防止由于以下原因引起的脱靶效应:(i)荧光蛋白的错误插入,(ii)荧光蛋白对融合蛋白的干扰或(iii) CRISPR / Cas9对特定基因组DNA的损伤。在此协议 中,我们提供了逐步生成系统管线的逐步描述,以生成和验证纯合的荧光敲入细胞系。我们使用配对的Cas9D10A切口酶方法将标签有效插入特定通过同源性指导修复的基因组位点,具有最小的脱靶效应。对每个细胞克隆进行全基因组测序既费时又费钱。因此,我们已经开发了一种有效的验证流水线,可用于生成细胞系,包括接合点PCR,Southern印迹分析,Sanger测序,显微镜,Western印迹分析和用于细胞周期动态的活细胞成像。该协议需要6–9周。使用该协议,可以将多达70%的靶向基因用荧光蛋白纯合标记,并导致融合蛋白的生理水平和表型功能性表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号